Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 27093153

Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncotarget
Publication date
2016 May 17
First author
Wang JH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Wang JH
      type
      Author
    2. name
      Wang L
      type
      Author
    3. name
      Liu CC
      type
      Author
    4. name
      Xia ZJ
      type
      Author
    5. name
      Huang HQ
      type
      Author
    6. name
      Lin TY
      type
      Author
    7. name
      Jiang WQ
      type
      Author
    8. name
      Lu Y
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Wang JH
      type
      Author
    2. name
      Wang L
      type
      Author
    3. name
      Liu CC
      type
      Author
    4. name
      Xia ZJ
      type
      Author
    5. name
      Huang HQ
      type
      Author
    6. name
      Lin TY
      type
      Author
    7. name
      Jiang WQ
      type
      Author
    8. name
      Lu Y
      type
      Author
    bibliography ids
    1. nci-bib-47d13e9a1e2657d4de3b0874
    book metadata
    content sha256
    5376671f14a8007c04d6bc88e6649fcd21aef51d024edf36faee95df5f710f93
    document type
    citation
    dois
    1. 10.18632/oncotarget.8647
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27093153
    immutable id
    pubmed:27093153@5376671f14a8007c04d6bc88e6649fcd21aef51d024edf36faee95df5f710f93
    journal
    abbreviation
    Oncotarget
    issn electronic
    1949-2553
    issn print
    Source null
    issue
    20
    name
    Oncotarget
    nlm unique id
    101532965
    pages
    29092-101
    volume
    7
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27093153
      provenance
      batch id
      fe5a46c92522c34737e8
      provider
      NCBI PubMed ESummary
      record sha256
      ae718564f8fd515bb8d96d7c1dccd9c96c92d3363eb103d5b452d55a671a74ee
      response sha256
      2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
      retrieved at
      2026-09-09T23:47:17.939307+00:00
      publication date
      display
      2016 May 17
      precision
      day
      year
      2016
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27093153/
      title
      Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice